LATEST ALERTS
Psychedelics
Psychedelics bill vetoed, but governor supports therapeutic use…
9th October 2023 - Daily news alerts | California, North America, United States |
FDA releases draft guidance for psychedelics research…
26th June 2023 - Daily news alerts | North America, United States |
House Armed Services Committee approves medical cannabis and psychedelics amendments…
23rd June 2023 - Daily news alerts | North America, United States |
Psychedelic Medicines Working Group established…
15th June 2023 - Daily news alerts | Nevada, North America, United States |
Governor signs several psychedelic and drug-related bills…
26th May 2023 - Daily news alerts | Minnesota, North America, United States |
Regulatory framework laid down for psychedelic medicines…
25th May 2023 - Daily news alerts | Colorado, North America, United States |
MPs to consider more a lenient approach to psilocybin…
16th May 2023 - Daily news alerts | Europe, United Kingdom |
OHA issues first psilocybin service centre licence…
8th May 2023 - Daily news alerts | North America, Oregon, United States |
Two Buttes put their heads together to save the world with plenty of weed!
1st April 2023 - News analysis |
Cannabinoids have been credited with many benefits to individual health. But now industry stakeholders are wondering if the hemp plant could be applied to an even bigger task – saving the planet
Advocates for psylocibin as therapeutic treatment push Canadian government
16th December 2022 - News analysis |
Canadian advocates for therapeutic access to psilocybin are ramping up their efforts to get the federal government to grant exemptions to the country’s drug laws so patients and healthcare providers can legally access the drug
Hope and concern as Colorado legalises the purchasing and use of psychedelics
8th December 2022 - News analysis |
A measure to allow the use of psychedelics in Colorado is a major step – but supporters worry it could lead to the sort of bad experience that would set back the progress of legalisation
Psychedelics on course to be decriminalised…
10th November 2022 - Daily news alerts | Colorado, North America, United States |
EU notified of intent to ban new synthetic psychoactive substances…
9th November 2022 - Daily news alerts | Europe, Finland |
What is attracting the American right to put cash and effort behind psychedelics?
19th October 2022 - Blogs |
It is not only cannabis that is attracting what might be thought unexpected investment and support from traditionally conservative, right-wing supporters and lobbyists in the US
Opposite sides attract, as Navajo oppose any bid to decriminalise use of peyote
22nd September 2022 - Blogs |
Drug legalisation as an issue truly does bring together some strange bedfellows – like the Navajo Nation and drug prohibitionists
HHC and other intoxicating cannabinoids move within legal limbo in Europe
16th September 2022 - News analysis |
As debate over the legalisation of recreational cannabis involves a growing number of European countries, the commercial demand for legal psychoactive alternatives to controlled cannabinoid variants is on the rise
A microdosing inhaler: just one of the many new innovations for psychedelics
26th August 2022 - News analysis |
A new conceptual inhaler designed around the idea of controlled microdosing could eventually lead to a product capable of administering precise amounts of active ingredients such as CBD, nicotine or even psychedelics
US DEA makes U-turn on psychedelics as senators call for more research support
8th August 2022 - News analysis |
The US Drug Enforcement Administration (DEA) has withdrawn its proposal to effectively ban five psychedelic compounds after receiving significant opposition from the research and advocacy community
Are psychedelics set to follow cannabis into mainstream medical acceptance?
21st July 2022 - Blogs , News analysis |
Psychedelics are having another moment in the spotlight. But is the heightened awareness just hype, or have these once-taboo substances been permanently rehabilitated?
UK government to fund research into psychedelic treatment for alcoholism
19th July 2022 - News analysis |
Biotechnology firm Awakn Life Sciences has secured UK government funding to accelerate the route to the UK and US markets for its proprietary ketamine-assisted therapy, which is designed to treat alcohol use disorder
A ‘milestone’ for psychedelics as clinical trial begins in US with FDA’s blessing
18th July 2022 - News analysis |
As the first federally approved psychedelics clinical trial begins in the US, there is broad but not total agreement among official bodies over legalising research into hallucinogenic substances
Mental health, addiction treatments with psychedelics: could the UK lead the way?
27th May 2022 - News analysis |
Strangely, Brexit and then the Covid-19 pandemic have combined to create ideal conditions for the UK to potentially become a leader in psychedelics research
